neonatale screening: behandelbare stofwisselingsziektenmetabern-educ.eu/img/pdf/morava_cours.pdf ·...

of 18 /18
26/01/2016 1 Neonatale screening: behandelbare stofwisselingsziekten prof. dr. Eva Morava Kindergeneeskunde, UZ Leuven Inborn errors of metabolism

Author: others

Post on 27-Apr-2020

41 views

Category:

Documents


0 download

Embed Size (px)

TRANSCRIPT

  • 26/01/2016

    1

    Neonatale screening: behandelbare stofwisselingsziektenprof. dr. Eva MoravaKindergeneeskunde, UZ Leuven

    Inborn errors of metabolism

  • 26/01/2016

    2

    Paddington station

    General features of inborn errors of metabolismA. Affected infants are usually normal at

    birth

    B. The most frequent genetic background is: autosomal recessive inheritance

    C. There is a significant intra-individual clinical variability with the same genetic diagnosis

    D. All of the above

  • 26/01/2016

    3

    General features of inborn errors of metabolismA. Affected infants are usually normal at

    birth

    B. The most frequent genetic background is: autosomal recessive inheritance

    C. There is a significant intra-individual clinical variability with the same genetic diagnosis

    D. All of the above

    General features of inborn errors of metabolism

    Neurologic abnormalitie

    s

    Growth Failure

    Feeding intolerances

    Metabolic derangemen

    tHypotoniaHypertoniaSeizures

    Developmental delay

    Abnormal growthFailure to thrive

    VomitingDiarrhea

    AcidosisHyperammonemi

    a

  • 26/01/2016

    4

    Introduction to Inborn Errors of Metabolism

    B C

    D

    COFACTOR

    X

    ENZYME1

    E

    ENZYME2

    ENZYME2

    A

    Inborn errors of metabolism• Disorders of intoxication

    • Disorders of energy metabolism

    • Complex molecules

  • 26/01/2016

    5

    Inborn errors of metabolism• Disorders of intoxication

    • Disorders of energy metabolism

    • Complex molecules

    IntoxicationInsufficient breakdown of normal food ingredients

    leading to increase of partially degraded products

    EXAMPLE: abnormal amino acid degradation

    Metabolic acidosis, elevated lactate and ammonia

    Vomiting, somnolence, seizures, hyperventillation

  • 26/01/2016

    6

    Case 1

    Case 1: Significant Findings• healthy AGA newborn who became lethargic at age of 5

    days over 2-3days prior to admission

    • clinical: significant weight loss (dehydration), unusual odor, unresponsive, twitching, normal morphology exam

  • 26/01/2016

    7

    Brief Differential Diagnosis of the Sick Infant• infectious etiology

    o sepsis vs viral encephalopathy (Herpes)

    • inborn error of metabolism suggested byo unusual odoro metabolic acidosiso CNS involvemento hyperammonemia

    THE PRESENTATION OF ACUTE METABOLIC DISEASES IN INFANCY IS CLINICALLY

    INDISTINGUISHABLE FROM SEPSIS

  • 26/01/2016

    8

    Case 1: Diagnostic Findings• pH 7.12, HC03 9, NH3 140, anion gap 28, ketones 3+, glucose 168• laboratory: metabolic acidosis with increased anion gap,

    hyperammonemia, pancytopenia

    • urine organic acids: massive isovalerylglycine(2752mg/gCR; nl = 0)

    3-OHisovaleric acid massive ketosis

    • diagnosis = isovaleric acidemia(isovalerylCoA dehydrogenase deficiency)

    An increased anion gap occurs due toA. Elevated lactic acid levels in

    blood

    B. Elevated ketone concentration in blood

    C. Increased amount of organic acids in blood

    D. All of the above

  • 26/01/2016

    9

    An increased anion gap occurs due toA. Elevated lactic acid levels in

    blood

    B. Elevated ketone concentration in blood

    C. Increased amount of organic acids in blood

    D. All of the above

    Anion gapDifference between positive and negative ions

    Na + K – Cl - bicarbonate = 14-16 mmol/l

    Abnormal anion gap: 28 mmol/lUsually contains acids: organic acids, like lactic acid, ketoacids

  • 26/01/2016

    10

    Isovaleric Acidemia: Metabolic Defect

    leucine

    ketoisocaproic acid

    isovalerylCoA

    methylcrotonylCoA

    IsovalerylCoAdehydrogenase(Isovaleric acidemia)

    Treatment: Acute Phase• discontinue all protein nutrients (never longer

  • 26/01/2016

    11

    Carnitine/GlycineTherapy: Mechanism

    carnitine + isovalerylCoA

    isovalerylcarnitine

    isovalerylcarnitine

    protein leucine

    leucine

    transferase

    freely excreted by kidneys

    MITOCHONDRION

  • 26/01/2016

    12

    Treatment: Recovery and later episodes

    • Continue high caloric input to prevent catabolism

    • Provide 1 g (0.7-1.4 g)/kg/d protein

    • Leucine-free formula

    • Enteral carnitine 50-100 mg/kg/d

    Isovaleric Acidemia: Results of Treatment

  • 26/01/2016

    13

    Disorders without acidosis

    Phenylalanine

    Tyrosine

    MelaninDopamine

    Phenylalanine hydroxylase

    (Phenylketonuria)

    Phenylpyruvic acid

    BH4

    Disorders without acidosis

  • 26/01/2016

    14

    Treatment

    Protein restrictionHigh caloric dietEssential amino acids in formula-------------------------------------------Kuvan: BH4 - PAH chaperon

    Dietary treatment in PKU

  • 26/01/2016

    15

    Untreated PKU

    Phenylalanine ammonia lyase treatment in PKU

  • 26/01/2016

    16

    Newborn Screening: Presymptomatic Diagnosis

    >20 inborn metabolic diseases detected by MSMS

    Newborn Screening: Presymptomatic Diagnosis

    Preventable diseaseCommonKnown disease course Treatable

    Reliable diagnosisCheap method

  • 26/01/2016

    17

    Newborn Screening: Presymptomatic Diagnosis

    Preventable (early dg.)Common (?)Known disease course !Treatable (+/-)

    Reliable diagnosis!Cheap method (21 euros)

    Estimated Frequency of IEMs Among Newborn Infants (before 2004)• Phenylketonuria 1 in 15,000• Organic Acidemias 1 in 20,000• MCAD deficiency 1 in 20,000• Fatty Acid Oxidation disorders 1 in 50,000• Galactosemia 1 in 60,000• Biotinidase defect 1 in 60,000• Urea Cycle Disorders 1 in 70,000• Tyrosinemia type I 1 in 100,000• Homocystinuria 1 in 470,000• MSUD 1 in 900,000

    Most inborn errors of metabolism are : < 1 in 50,000 live births

  • 26/01/2016

    18

    Estimated Frequency of IEMs Among Newborn Infants (before 2004)• Phenylketonuria 1 in 15,000• Organic Acidemias 1 in 20,000• MCAD deficiency 1 in 20,000• Fatty Acid Oxidation disorders 1 in 50,000• Galactosemia 1 in 60,000• Biotinidase defect 1 in 60,000• Urea Cycle Disorders 1 in 70,000• Tyrosinemia type I 1 in 100,000• Homocystinuria 1 in 470,000• MSUD 1 in 900,000

    Most inborn errors of metabolism are : < 1 in 50,000 live births

    Newborn screening in Belgium

    Outcome in IEM